CMH :: Clinical and Molecular Hepatology

Statins for the Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

American Journal of Therapeutics.2023; 30(1): e17. CrossRef

Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation

Gastroenterology Insights.2023; 14(3): 249. CrossRef

Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives

Marko Mitrovic, Gabriella Sistilli, Olga Horakova, Martin Rossmeisl

European Journal of Clinical Investigation.2022;[Epub] CrossRef

Enfermedad hepática grasa relacionada a trastornos metabólicos

Revista Médica Basadrina.2022; 15(4): 85. CrossRef

Lower serum copper concentrations are associated with higher prevalence of nonalcoholic steatohepatitis: a matched case–control study

Huai Zhang, Kenneth I. Zheng, Pei-Wu Zhu, Sui-Dan Chen, Gang Li, Hong-Lei Ma, Liang-Jie Tang, Ou-Yang Huang, Christopher D. Byrne, Giovanni Targher, Xiao-Dong Wang, Ming-Hua Zheng

European Journal of Gastroenterology & Hepatology.2022; 34(8): 838. CrossRef

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease

International Journal of Molecular Sciences.2022; 23(13): 7280. CrossRef

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism

Hongmei Yan, Weiyun Wu, Xinxia Chang, Mingfeng Xia, Sicheng Ma, Liu Wang, Jian Gao

Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies

Maryam Ebadi, Stephen Ip, Rahima A. Bhanji, Aldo J. Montano-Loza

Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification

Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin

Jose D. Torres-Peña, Laura Martín-Piedra, Francisco Fuentes-Jiménez

Frontiers in Cardiovascular Medicine.2021;[Epub] CrossRef

Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases

Robert J. Wong, Nandita Kachru, Diane J. Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon

Journal of Clinical Gastroenterology.2021; 55(10): 891. CrossRef

iTRAQ‑based quantitative proteomics analysis of the hepatoprotective effect of melatonin on ANIT‑induced cholestasis in rats

Dingnan Wang, Han Yu, Yunzhou Li, Zongying Xu, Shaohua Shi, Dou Dou, Lili Sun, Zhili Zheng, Xinghua Shi, Xiulan Deng, Xianggen Zhong

Experimental and Therapeutic Medicine.2021;[Epub] CrossRef

Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine

Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi

Evidence-Based Complementary and Alternative Medicine.2020; 2020: 1. CrossRef

Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model

Neng Tanty Sofyana, Jiawen Zheng, Yuki Manabe, Yuta Yamamoto, Shigenobu Kishino, Jun Ogawa, Tatsuya Sugawara

Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy

Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini

Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(6): 1014. CrossRef

Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database

Jérôme Boursier, Sanatan Shreay, Cecile Fabron, Elodie Torreton, Jeremy Fraysse

Ethyl Acetate Fraction of Amomum xanthioides Ameliorates Nonalcoholic Fatty Liver Disease in a High-Fat Diet Mouse Model

Hwi-Jin Im, Seung-Ju Hwang, Jin-Seok Lee, Sung-Bae Lee, Ji-Yun Kang, Chang-Gue Son

Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming

Diabetes & Metabolism Journal.2020; 44(5): 640. CrossRef

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research

Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno

International Journal of Molecular Sciences.2020; 21(24): 9646. CrossRef

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Amedeo Lonardo, Simonetta Lugari, Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Mauro Maurantonio

Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures

Stefania Lama, Daniela Vanacore, Nadia Diano, Carla Nicolucci, Sonia Errico, Marcello Dallio, Alessandro Federico, Carmelina Loguercio, Paola Stiuso

Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach

Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis

Yan-Xiao Ji, Zan Huang, Xia Yang, Xiaozhan Wang, Ling-Ping Zhao, Pi-Xiao Wang, Xiao-Jing Zhang, Michele Alves-Bezerra, Lin Cai, Peng Zhang, Yue-Xin Lu, Lan Bai, Mao-Mao Gao, Huan Zhao, Song Tian, Yong Wang, Zhi-Xiang Huang, Xue-Yong Zhu, Yan Zhang, Jun Go

Prevention and management of gastroesophageal varices

Clinical and Molecular Hepatology.2018; 24(1): 20. CrossRef

Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action

Molecular Aspects of Medicine.2018; 64: 135. CrossRef

NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?

Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson

Current HIV/AIDS Reports.2018; 15(3): 212. CrossRef

Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction

Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, Dela Golshayan

Journal of Medicinal Chemistry.2018; 61(22): 9811. CrossRef

Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases

Francesca Bonomini, Elisa Borsani, Gaia Favero, Luigi Rodella, Rita Rezzani